New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
07:41 EDTNUVA, MDXG, AXGN, BAXS, SNN, RTIX, ANIK, OSIR, SMA, CNMD, GMED, BONECanaccord to hold a conference
Musculoskeletal Conference is being held in New Orleans, Louisiana on March 11.
News For GMED;ANIK;AXGN;CNMD;RTIX;MDXG;SMA;SNN;NUVA;OSIR;BAXS;BONE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 30, 2015
07:44 EDTMDXGMiMedx sees Q3 revenue $47M-$50M, consensus $48.68M
Sees Q3 operating profit 13%-15%.
07:43 EDTMDXGMiMedx reports Q2 EPS 5c, consensus 5c
Reports Q2 revenue $45.7M, consensus $44.99M.
July 29, 2015
16:40 EDTANIKAnika Therapeutics reports Q2 EPS 51c, consensus 34c
Subscribe for More Information
10:00 EDTNUVAOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: 3D Systems (DDD) upgraded to Neutral from Underperform at Longbow... AK Steel (AKS) upgraded to Outperform from Neutral at Macquarie... Ally Financial (ALLY) upgraded to Outperform from Neutral at Credit Suisse... Amazon.com (AMZN) upgraded to Buy from Hold at Stifel... Arrow Electronics (ARW) upgraded to Buy from Underperform at CLSA... Beacon Roofing (BECN) upgraded to Buy from Neutral at CL King... Citrix (CTXS) upgraded to Outperform at Baird... Commvault (CVLT) upgraded to Buy from Hold at Jefferies... FireEye (FEYE) upgraded on positive checks, business mdoel changes at Oppenheimer... Hibbett Sports (HIBB) upgraded to Neutral from Underperform at Sterne Agee CRT... Integra LifeSciences (IART) upgraded to Outperform at Raymond James... M/A-COM (MTSI) upgraded to Buy from Hold at Needham... Norsk Hydro (NHYDY) upgraded to Neutral from Underperform at Exane BNP Paribas... NuVasive (NUVA) upgraded to Outperform from Market Perform at Northland... SM Energy (SM) upgraded to Outperform from Market Perform at Raymond James... Scorpio Bulkers (SALT) upgraded to Buy from Hold at Deutsche Bank... Sirius XM (SIRI) upgraded to Buy from Hold at Wunderlich... Sprouts Farmers Markets (SFM) upgraded to Neutral from Underperform at Longbow... Supervalu (SVU) upgraded to Equal Weight from Underweight at Morgan Stanley... Waters (WAT) upgraded to Outperform from Market Perform at Wells Fargo... Wells Fargo (WFC) upgraded to Buy from Neutral at Guggenheim... Williams-Sonoma (WSM) upgraded to Overweight from Neutral at JPMorgan... YRC Worldwide (YRCW) upgraded to Strong Buy at Raymond James.
10:00 EDTMDXGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTNUVANuVasive upgraded to Outperform, expects strong 2H at Northland
As previously reported, Northland upgraded NuVasive to Outperform from Market Perform and raised its price target to $68 from $48. The firm expects 2H results to beat expectations and is a buyer ahead of Q3 results given strength in the U.S. spine market, operating performance, and leverage. Northland views the iGA platform as a "game changer" and checks show NuVasive continues to take market share.
07:44 EDTNUVANuVasive price target raised to $65 from $57 at Leerink
Leerink raised its price target for NuVasive to $65 saying the margin improvement story "has legs" following the company's Q2 results. The firm reiterates an Outperform rating on the stock.
07:22 EDTNUVANuVasive upgraded to Outperform from Market Perform at Northland
06:28 EDTMDXGMiMedx downgraded to Buy from Strong Buy at Needham
Needham downgraded MiMedx to Buy from Strong Buy with a $15 price target. The firm said MiMedx faces more difficult comps the rest of the year and downgraded shares based on limited upside to consensus estimates and valuation.
July 28, 2015
16:31 EDTNUVANuVasive reaches definitive agreement with U.S. DOJ
Subscribe for More Information
16:20 EDTNUVANuVasive raises 2015 EPS outlook to $1.17 from $1.10, consensus $1.12
Sees 2015 revenue $810M, consensus $812.22M.
16:19 EDTNUVANuVasive reports Q2 EPS 31c, consensus 25c
Subscribe for More Information
16:18 EDTNUVANuVasive enters $13.5M settlement of Justice Department
NuVasive announced that it has reached a definitive settlement with the U.S. Department of Justice related to the subpoena issued to the company by the Office of Inspector General of the Department of Health and Human Services in 2013. NuVasive admits no wrongdoing as part of the settlement. On April 29, the company announced that it had reached an agreement in principle to settle the investigation with the DOJ. The company has now entered into a definitive settlement agreement with the United States, acting through DOJ and on behalf of OIG, the Defense Health Agency, the Office of Personnel Management, and the U.S. Department of Veteran Affairs. Under the terms of the settlement agreement, the company will pay $13.5M, plus fees and accrued interest. The settlement is neither an admission of liability or wrongdoing by the company nor a concession by the United States that its claims are not well founded. The company was not required to enter into a corporate integrity agreement by the OIG as part of the settlement.
15:21 EDTNUVANotable companies reporting after market close
Subscribe for More Information
July 27, 2015
19:03 EDTBONEBacterin to acquire X-spine Systems, change name of new company to Xtant Medical
Bacterin announced that it intends to purchase the outstanding shares of privately held X-spine Systems in exchange for approximately 4.24M shares of Bacterin common stock and approximately $60M in cash, subject to customary working capital adjustments, and including the extinguishment of approximately $13M of X-spine debt. The transaction will position the combined company as a comprehensive supplier for spine surgery procedures that offers both hardware and biologics through a more substantial national distribution footprint. Concurrent with the closing, Bacterin International Holdings, Inc. will change its name to Xtant Medical Holdings, Inc. Dr. David Kirschman, currently X-spine CEO, will join the management team and serve as EVP and Chief Scientific Officer of Xtant Medical Holdings, Inc. He will also be president of X-spine Systems, the hardware subsidiary. Dr. Kirschman will also be appointed to the Xtant Medical Holdings, Inc. board.
July 22, 2015
10:01 EDTCNMDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:58 EDTCNMDCONMED downgraded on outlook concerns at Northland
Subscribe for More Information
07:52 EDTCNMDCONMED downgraded to Market Perform from Outperform at Northland
Subscribe for More Information
July 21, 2015
16:04 EDTCNMDCONMED backs FY15 adjusted EPS $1.82-$1.92, consensus $1.85
Subscribe for More Information
16:02 EDTCNMDCONMED reports Q2 adjusted EPS 36c, consensus 44c
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use